Published in Obstet Gynecol Int on June 29, 2010
Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA (2001) 5.96
Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med (2006) 5.69
2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis (2007) 3.11
Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol (2006) 3.08
Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine (2006) 2.51
Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol (1998) 2.37
Treatment for cervical intraepithelial neoplasia and risk of preterm delivery. JAMA (2004) 2.26
Influence of diagnostic and therapeutic procedures on the distribution of cervical intraepithelial neoplasia. Cancer (1966) 1.92
Pregnancy outcome after loop electrosurgical excision procedure: a systematic review. Obstet Gynecol (2003) 1.43
Biopsy correlates of abnormal cervical cytology classified using the Bethesda system. Gynecol Oncol (2001) 1.17
Pregnancy outcome after loop electrosurgical excision procedure for the management of cervical intraepithelial neoplasia. Arch Gynecol Obstet (2005) 1.10
The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease. J Leukoc Biol (2008) 1.09
A "see and treat" management for high-grade squamous intraepithelial lesion pap smears. J Low Genit Tract Dis (2003) 1.07
A prospective evaluation of "see and treat" in women with HSIL Pap smear results: is this an appropriate strategy? J Low Genit Tract Dis (2005) 1.02
2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities. J Low Genit Tract Dis (2002) 1.01
High intraepithelial expression of estrogen and progesterone receptors in the transformation zone of the uterine cervix. Am J Obstet Gynecol (2003) 0.87
Cervical carcinoma in situ and use of depot-medroxyprogesterone acetate (DMPA). WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Contraception (1995) 0.82
Cervical cancer prevention and hormonal contraception. Lancet (2007) 0.80
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc Natl Acad Sci U S A (2011) 3.99
Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas. Clin Cancer Res (2013) 3.25
Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up. Am J Surg Pathol (2002) 2.70
Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One (2010) 2.62
Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR. J Clin Microbiol (2009) 2.29
The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations. Cancer (2010) 2.13
Longitudinal assessment of infecting serovars of Chlamydia trachomatis in Seattle public health clinics: 1988-1996. Sex Transm Dis (2003) 1.54
Alternate molecular genetic pathways in ovarian carcinomas of common histological types. Hum Pathol (2007) 1.49
Biomarkers of progestin therapy resistance and endometrial hyperplasia progression. Am J Obstet Gynecol (2012) 1.43
An evaluation of cervical cancer in women age sixty and over. Gynecol Oncol (2008) 1.43
Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation. Mol Cancer Res (2007) 1.40
Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics. J Natl Compr Canc Netw (2009) 1.25
Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer. Gynecol Oncol (2008) 1.15
Follow-up of in situ and early-stage fallopian tube carcinoma in patients undergoing prophylactic surgery for proven or suspected BRCA-1 or BRCA-2 mutations. Am J Surg Pathol (2004) 1.13
Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas. Mol Cancer (2009) 1.12
Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy. Am J Obstet Gynecol (2006) 1.12
Inadequate prenatal care and risk of preterm delivery among adolescents: a retrospective study over 10 years. Am J Obstet Gynecol (2010) 1.09
Diagnosing endometrial hyperplasia: why is it so difficult to agree? Am J Surg Pathol (2008) 1.08
Loss of function germline mutations in RAD51D in women with ovarian carcinoma. Gynecol Oncol (2012) 1.06
MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival. Genes Chromosomes Cancer (2010) 1.05
Legal outcomes of sexual assault. Am J Obstet Gynecol (2003) 1.00
Immunizing school-age children and adolescents: experience from low- and middle-income countries. Vaccine (2009) 0.91
Cervical cancer screening. J Natl Compr Canc Netw (2010) 0.87
PAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasia. Int J Gynecol Pathol (2012) 0.87
Early surgical abortion: efficacy and safety. Am J Obstet Gynecol (2002) 0.86
Epithelioid trophoblastic tumor: review of a rare neoplasm of the chorionic-type intermediate trophoblast. Arch Pathol Lab Med (2006) 0.85
53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomes. Gynecol Oncol (2012) 0.83
A comprehensive women's health care center: are gynecologists offering primary care? Am J Obstet Gynecol (2006) 0.82
Characteristics of women with ovarian carcinoma who have BRCA1 and BRCA2 mutations not identified by clinical testing. Gynecol Oncol (2012) 0.81
Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy. Obstet Gynecol (2010) 0.81
Achieving high coverage of H1N1 influenza vaccine in an ethnically diverse obstetric population: success of a multifaceted approach. Infect Dis Obstet Gynecol (2011) 0.79
Prevalence of vitamin D insufficiency and clinical associations among veiled East African women in Washington State. J Womens Health (Larchmt) (2007) 0.79
Sexual function in women on estradiol or venlafaxine for hot flushes: a randomized controlled trial. Obstet Gynecol (2014) 0.78
Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinoma. Int J Gynecol Pathol (2015) 0.76
High Prevalence of Sexual Dysfunction in a Vulvovaginal Specialty Clinic. J Low Genit Tract Dis (2016) 0.75
Angiogenic alterations associated with circulating neoplastic DNA in ovarian carcinoma. Transl Oncol (2012) 0.75
How homogeneous are comparison groups in any study evaluating techniques of embryo transfer? Hum Reprod (2002) 0.75
Defining an appropriate threshold for the diagnosis of serous borderline tumor of the ovary: when is a full staging procedure unnecessary? Int J Gynecol Pathol (2008) 0.75